bacterial ribosome inhibitor (Abbott)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Namebacterial ribosome inhibitor (Abbott)
Drug Alias NameNRI (Abbott)novel ribosome inhibitor (Abbott)NRI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial proteins synthesis inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A